Accretion Nutraveda (BOM:544694) General and Admin. Expense: ₹2.3 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544694 Accretion Nutraveda Ltd BOM:544694
21 GF Score
Price ₹283.95
! 3 Warning Signs
View Full Analysis

What is Accretion Nutraveda General and Admin. Expense?

Accretion Nutraveda BOM:544694 21 General and Admin. Expense is ₹2.3 Mil as of Mar. 2026. GuruFocus rates BOM:544694 with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Accretion Nutraveda's General and Admin. Expense for the six months ended in Mar. 2026 was ₹0.0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.3 Mil.

Accretion Nutraveda General and Admin. Expense Related Terms

Accretion Nutraveda General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Accretion Nutraveda's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Nutraveda General and Admin. Expense Chart

Accretion Nutraveda Annual Data
Trend Mar23 Mar24 Mar25 Mar26
General and Admin. Expense
0.28 0.43 0.88 0.00

Accretion Nutraveda Semi-Annual Data
Mar23 Mar24 Mar25 Sep25 Mar26
General and Admin. Expense 0.00 0.00 0.00 2.28 0.00
BOM:544694
21GF Score
Accretion Nutraveda Ltd BOM:544694
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Nutraveda General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹2.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of ₹2.3 Mil mean?
Accretion Nutraveda (BOM:544694) has a General and Admin. Expense of ₹2.3 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Accretion Nutraveda and its competitors.
Is Accretion Nutraveda's General and Admin. Expense too high?
Accretion Nutraveda's current General and Admin. Expense is ₹2.3 Mil. Overall, Accretion Nutraveda has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Nutraveda's General and Admin. Expense compare to ZTS?
Accretion Nutraveda's General and Admin. Expense of ₹2.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Accretion Nutraveda and its competitors. Accretion Nutraveda's current General and Admin. Expense is ₹2.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Nutraveda stock overvalued right now?
Accretion Nutraveda (BOM:544694) has a current General and Admin. Expense of ₹2.3 Mil. The current General and Admin. Expense is ₹2.3 Mil. Accretion Nutraveda's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Accretion Nutraveda (BOM:544694), the current General and Admin. Expense is ₹2.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Nutraveda Business Description

Address 27 Xcelon Industrial Park-1, Vasna-Chacharwadi, Taluka Sanand, Ahmedabad, GJ, IND, 382213
Accretion Nutraveda Ltd is engaged in the business of the Manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, Oral Powders, External Preparation and Oils. It is a healthcare focused Company specializing in contract manufacturing, serving domestic as well as export markets in various countries like Sri Lanka, Singapore and the USA. The company offers a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science. Its product portfolio includes Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support.
21GF Score

Get the complete analysis for BOM:544694

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹283.95
Price